Stocktoria
Enveric Biosciences, Inc. ENVB
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2009-07-21
Enveric Biosciences, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | 20.4% | 20.9% | 21.1% | 19.2% |
| Operating margin | — | — | — | — | — | — | -5.8% | -16.6% | -22.4% | -14.9% |
| Net margin | — | — | — | — | — | — | -6.0% | -39.3% | -18.7% | -7.7% |
| Return on assets | -172.1% | -310.6% | -402.1% | -94.5% | -183.3% | -167.6% | -2215.9% | -57.0% | -17.4% | -7.0% |
| Return on equity | -210.0% | -601.1% | -883.9% | -125.9% | -219.6% | -201.0% | 133.1% | -157.1% | -46.7% | -23.8% |
| Debt / equity | — | — | — | — | — | — | -0.41× | 0.00× | 0.10× | 0.17× |
| Current ratio | 5.38 | 1.84 | 1.53 | 4.61 | 6.48 | 3.35 | 0.01 | 0.68 | 0.48 | 0.79 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.